Nephros Inc financial data

Symbol
NEPH on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
380 Lackawanna Place, South Orange, NJ
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 24, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 488 % -3.58%
Quick Ratio 174 % +23.6%
Debt-to-equity 27.7 % +2.29%
Return On Equity 0.9 %
Return On Assets 0.67 %
Operating Margin 0.04 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10.6M shares +0.54%
Common Stock, Shares, Outstanding 10.5M shares +0.01%
Entity Public Float 14.1M USD +35.2%
Common Stock, Value, Issued 11K USD +10%
Weighted Average Number of Shares Outstanding, Basic 10.5M shares +1.34%
Weighted Average Number of Shares Outstanding, Diluted 10.6M shares +2.08%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 14.2M USD -0.53%
Research and Development Expense 906K USD +3.78%
Operating Income (Loss) 6K USD
Nonoperating Income (Expense) 83K USD
Income Tax Expense (Benefit) 15K USD
Net Income (Loss) Attributable to Parent 74K USD
Earnings Per Share, Basic 0.01 USD/shares
Earnings Per Share, Diluted 0.01 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.76M USD -12.7%
Accounts Receivable, after Allowance for Credit Loss, Current 1.78M USD +19.1%
Inventory, Net 2.62M USD +5.87%
Assets, Current 8.3M USD -1.27%
Property, Plant and Equipment, Net 161K USD +5.92%
Operating Lease, Right-of-Use Asset 1.36M USD -24.8%
Goodwill 759K USD 0%
Other Assets, Noncurrent 50K USD -41.9%
Assets 11.2M USD -5.49%
Accounts Payable, Current 649K USD -25.7%
Accrued Liabilities, Current 565K USD -28.8%
Liabilities, Current 1.56M USD -26.1%
Operating Lease, Liability, Noncurrent 1.05M USD -24.7%
Liabilities 2.63M USD -25.1%
Retained Earnings (Accumulated Deficit) -144M USD +0.05%
Stockholders' Equity Attributable to Parent 8.36M USD +49.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 8.59M USD +2.72%
Liabilities and Equity 11.2M USD -5.49%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -672K USD -343%
Net Cash Provided by (Used in) Financing Activities -2K USD +97.3%
Common Stock, Shares Authorized 40M shares 0%
Common Stock, Shares, Issued 10.5M shares +0.01%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -674K USD -434%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1K USD 0%
Deferred Tax Assets, Valuation Allowance 20M USD -4.96%
Deferred Tax Assets, Gross 20.5M USD -5.22%
Operating Lease, Liability 1.39M USD -24.2%
Depreciation 11K USD +10%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -1.58M USD +78.7%
Lessee, Operating Lease, Liability, to be Paid 1.59M USD -26.2%
Property, Plant and Equipment, Gross 1.17M USD +5.03%
Operating Lease, Liability, Current 343K USD -22.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 450K USD +3.45%
Lessee, Operating Lease, Liability, to be Paid, Year One 435K USD -22.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 197K USD -37.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 450K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 15.6M USD -6.42%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 251K USD -44.2%
Additional Paid in Capital 153M USD +0.1%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 32K USD -23.8%
Share-based Payment Arrangement, Expense -27K USD
Interest Expense 1K USD 0%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%